West Pharmaceutical Services, Inc. (WST)

WST Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22,796	26,053	17,424	34,744	20,944	11,123
Market Cap Growth	-21.43%	49.53%	-49.85%	65.89%	88.30%	53.17%
Enterprise Value	22,613	25,461	16,995	34,372	20,754	10,995
Last Close Price	314.77	351.51	234.39	465.97	280.91	148.59
PE Ratio	46.70	44.61	30.32	53.75	61.47	46.29
PS Ratio	8.02	8.83	6.04	12.27	9.76	6.05
PB Ratio	8.29	9.04	6.49	14.88	11.29	7.07
P/FCF Ratio	70.88	62.85	39.65	105.09	70.26	46.19
P/OCF Ratio	32.45	33.55	24.07	59.49	44.33	30.29
EV/Sales Ratio	7.86	8.63	5.89	12.14	9.67	5.98
EV/EBITDA Ratio	30.37	30.03	19.14	38.40	39.03	27.53
EV/EBIT Ratio	38.06	35.84	22.15	44.47	49.11	37.15
EV/FCF Ratio	70.32	61.43	38.68	103.97	69.62	45.66
Debt / Equity Ratio	0.11	0.11	0.12	0.14	0.18	0.21
Debt / EBITDA Ratio	0.40	0.35	0.35	0.36	0.60	0.79
Debt / FCF Ratio	0.96	0.75	0.72	0.98	1.11	1.37
Asset Turnover	0.77	0.79	0.83	0.93	0.84	0.85
Inventory Turnover	4.50	4.28	4.41	4.73	4.95	5.48
Quick Ratio	2.05	2.07	2.73	2.13	1.99	2.22
Current Ratio	3.00	2.88	3.70	2.93	2.73	3.10
Return on Equity (ROE)	17.78%	21.32%	23.34%	31.59%	20.20%	16.28%
Return on Assets (ROA)	10.00%	11.93%	13.84%	15.82%	10.29%	8.56%
Return on Capital (ROIC)	11.91%	14.34%	16.94%	19.93%	12.92%	10.58%
Earnings Yield	2.19%	2.28%	3.36%	1.90%	1.65%	2.17%
FCF Yield	1.41%	1.59%	2.52%	0.95%	1.42%	2.16%
Dividend Yield	0.27%	0.22%	0.31%	0.15%	0.23%	0.41%
Payout Ratio	12.46%	9.61%	9.23%	7.72%	13.89%	18.66%
Buyback Yield / Dilution	1.95%	0.66%	0.66%	-0.66%	-0.53%	-0.14%
Total Shareholder Return	2.22%	0.88%	0.97%	-0.51%	-0.30%	0.28%

Source: S&P Capital IQ. Standard template. Financial Sources.